MAIA Biotechnology, Inc.MAIANYSE
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank100
5Y CAGR+300.2%
Year-over-Year Change
Year-over-year SG&A expense growth
5Y CAGR
+300.2%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
1026.4x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 323343.56% |
| Q3 2025 | 46.15% |
| Q2 2025 | -7.75% |
| Q1 2025 | 9.45% |
| Q4 2024 | 33.80% |
| Q3 2024 | -13.71% |
| Q2 2024 | 8.29% |
| Q1 2024 | -38.80% |
| Q4 2023 | 12.92% |
| Q3 2023 | 14.08% |
| Q2 2023 | 3.88% |
| Q1 2023 | 10.36% |
| Q4 2022 | -34.54% |
| Q3 2022 | 108.11% |
| Q2 2022 | -3.19% |
| Q1 2022 | -8.37% |
| Q4 2021 | 29.48% |
| Q3 2021 | 34.01% |
| Q2 2021 | 9.05% |
| Q1 2021 | -71.67% |
| Q4 2020 | 315.02% |
| Q3 2020 | 0.00% |